Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents.

Authors

Pardeep Kumar, Thomas Jefferson UniversityFollow
Sushil Kumar Tripathi, Thomas Jefferson UniversityFollow
Chang-Po Chen, Henan Normal University
Neil Mehta, Thomas Jefferson UniversityFollow
Bishnuhari Paudyal, Thomas Jefferson UniversityFollow
Eric Wickstrom, Thomas Jefferson UniversityFollow
Mathew L. Thakur, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

2-1-2016

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in Cancer Biotherapy and Radiopharmaceuticals

Volume 31, Issue 1, February 2016, Pages 29-36.

Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/cbr.2015.1947

Abstract

OBJECTIVE: The authors have conjugated chelating agents (DOTA and NODAGA) with a peptide (pituitary adenylate cyclase-activating peptide [PACAP] analogue) that has a high affinity for VPAC1 receptors expressed on cancer cells. To determine a suitable chelating agent for labeling with (68)Ga, they have compared the labeling kinetics and stability of these peptide conjugates.

METHODS: For labeling, (68)GaCl3 was eluted in 0.1 M HCl from a [(68)Ge-(68)Ga] generator. The influences of peptide concentration, pH, and temperature on the radiolabeling efficiency were studied. The stability was evaluated in saline, human serum, DTPA, transferrin, and metallic ions (FeCl3, CaCl2, and ZnCl2). Cell binding assay was performed using human breast cancer cells (T47D). Tissue biodistribution was studied in normal athymic nude mice.

RESULTS: Optimal radiolabeling (>95.0%) of the DOTA-peptide conjugates required a higher (50°C-90°C) temperature and 10 minutes of incubation at pH 2-5. The NODAGA-peptide conjugate needed incubation only at 25°C for 10 minutes. Both radiocomplexes were stable in saline, serum, as well as against transchelation and transmetallation. Cell binding at 37°C for 15 minutes of incubation with (68)Ga-NODAGA-peptide was 34.0% compared to 24.5% for (68)Ga-DOTA-peptide. Tissue biodistribution at 1 hour postinjection of both (68)Ga-labeled peptide conjugates showed clearance through the kidneys.

CONCLUSIONS: NODAGA-peptide showed more convenient radiolabeling features than that of DOTA-peptide.

Recommended Citation

Kumar, Pardeep; Tripathi, Sushil Kumar; Chen, Chang-Po; Mehta, Neil; Paudyal, Bishnuhari; Wickstrom, Eric; and Thakur, Mathew L., "Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents." (2016). Department of Radiology Faculty Papers. Paper 44.
https://jdc.jefferson.edu/radiologyfp/44

PubMed ID

26844850